Non disponible en dehors du Royaume-Uni et de l'Irlande
Application
Used in the total synthesis of Macquarimicins and in the total synthesis of the macrolide RK-397.
Chiral building block in the enantioselective syntheses of hydroxyisoxazolidines and (+)-cis-sylvaticin, a potential antitumor agent.
Used to synthesize inhibitors of fatty acid oxidation as potential metabolic modulators.
Legal Information
Manufactured under license by Sterling Pharma Solutions Limited, using Jacobsen HKR technology.
Packaging
5, 25 g in glass bottle
Ce produit répond aux critères suivants: